{"id":9211,"date":"2021-07-07T18:50:34","date_gmt":"2021-07-07T16:50:34","guid":{"rendered":"https:\/\/www.nicox.com\/about-us\/"},"modified":"2025-09-04T10:24:54","modified_gmt":"2025-09-04T08:24:54","slug":"about-us","status":"publish","type":"page","link":"https:\/\/www.nicox.com\/fr\/about-us\/","title":{"rendered":"A propos de Nicox"},"content":{"rendered":"\n<div class=\"c-page-title c-wrapper\">\n\n    <div class=\"[ c-container ] [ u-align-center ]\" data-variant=\"narrow-column\">\n    \n        <h1 class=\"[ c-page-title__text ] [ u-text-base sm:u-text-plus-1 u-weight-bold ] [  ]\">\n\n            A propos de Nicox\n            \n        <\/h1>\n\n        <hr class=\"[ c-page-title__hr ] [ u-color-blue-4 ]\">\n    \n    <\/div>\n\n<\/div>\n\n\n<section class=\"[ c-centered-column c-wrapper ] [ u-vertical-padding ] [   ]\">\n\n    <div class=\"c-block-anchor\" id=\"visible-science\"><\/div>\n\n    <div class=\"c-container c-centered-column__header\" data-variant=\"wide-column\">\n\n                    \n            <h2 class=\"[ c-centered-column__title ] [ u-text-plus-4 md:u-text-plus-5 lg:u-text-plus-6 u-weight-light ]\" data-variant=\"flush\">\n                Visible science\n            <\/h2>\n\n        \n            \n    <\/div>\n\n    <div class=\"[ c-container ] [ c-text-content ]\" data-variant=\"narrow-column\">\n\n        \n\n<h3 class=\"wp-block-heading\">Maintenir la vision et am\u00e9liorer la sant\u00e9 oculaire<\/h3>\n\n\n\n<p>Nicox est une soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie d\u00e9veloppant des solutions innovantes visant au maintien de la vision et \u00e0 l&rsquo;am\u00e9lioration de la sant\u00e9 oculaire. <\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"683\" height=\"512\" src=\"https:\/\/www.nicox.com\/wp-content\/uploads\/Nicox_opticien.jpg\" alt=\"\" class=\"wp-image-10778\"\/><\/figure>\n\n\n\n<p>Le principal programme du <a href=\"https:\/\/www.nicox.com\/fr\/portefeuille-de-therapeutiques-ophtalmiques\/\">portefeuille ophtalmique<\/a> de Nicox, <a href=\"https:\/\/www.nicox.com\/fr\/portefeuille-de-therapeutiques-ophtalmiques\/#portfolio\">NCX 470<\/a>, a achev\u00e9 avec succ\u00e8s la &nbsp;phase 3 de d\u00e9veloppement clinique pour le glaucome aux \u00c9tats-Unis et en Chine, avec un programme de Phase 3 distinct en cours au Japon. Le portefeuille ophtalmique comprend \u00e9galement un candidat au stade d\u2019\u00e9valuation pr\u00e9clinique pour un d\u00e9veloppement dans les maladies de la r\u00e9tine, <a href=\"https:\/\/www.nicox.com\/fr\/portefeuille-de-therapeutiques-ophtalmiques\/#portfolio\">NCX 1728<\/a>, et un candidat m\u00e9dicament au stade clinique pour la s\u00e9cheresse oculaire, <a href=\"https:\/\/www.nicox.com\/fr\/portefeuille-de-therapeutiques-ophtalmiques\/#portfolio\">NCX 4251<\/a>, licenci\u00e9 exclusivement \u00e0 un partenaire pour le march\u00e9 chinois. La Soci\u00e9t\u00e9 a deux produits licenci\u00e9s commercialis\u00e9s aux Etats Unis, <a href=\"https:\/\/www.nicox.com\/fr\/portefeuille-de-therapeutiques-ophtalmiques\/#portfolio\">VYZULTA<sup>\u00ae<\/sup><\/a> (solution ophtalmique de latanoprost\u00e8ne bunod), 0,024% pour les patients atteints de glaucome \u00e0 angle ouvert et <a href=\"https:\/\/www.nicox.com\/fr\/portefeuille-de-therapeutiques-ophtalmiques\/#portfolio\">ZERVIATE<sup>\u00ae<\/sup><\/a> (solution ophtalmique de cetirizine), 0,24% pour les patients atteints de conjonctivite allergique. ZERVIATE est aussi commercialis\u00e9 en Chine.<\/p>\n\n\n\n    <\/div>\n\n<\/section>\n\n\n<section class=\"[ c-wrapper c-leadership ] [  u-bg-blue-7 u-color-white ]\">\n\n    <div class=\"c-block-anchor\" id=\"leadership-team\"><\/div>\n\n    <div class=\"c-container\" data-variant=\"wide-column\">\n\n        <hr class=\"u-color-white\">\n\n                \n            <h2 class=\"[ c-leadership__title ] [ u-text-plus-1 sm:u-text-plus-2 u-weight-bold ]\">\n                Equipe dirigeante\n            <\/h2>\n        \n        \n        \n            <div class=\"[ c-leadership__intro ] [ u-gap-top-base ]\">\n        \n                <p>La Soci\u00e9t\u00e9 est dirig\u00e9e par une \u00e9quipe de professionnels exp\u00e9riment\u00e9s dont l\u2019expertise combin\u00e9e couvre la recherche, le d\u00e9veloppement clinique, les interactions r\u00e9glementaires, la finance, le \u2018business development\u2019, le \u2018corporate development\u2019, la gestion d\u2019alliances et la communication. Cette exp\u00e9rience a \u00e9t\u00e9 acquise dans des soci\u00e9t\u00e9s pharmaceutiques et des soci\u00e9t\u00e9s de biotechnologie de premier plan.<\/p>\n\n\n            <\/div>\n        \n        \n                \n            <div class=\"[ c-accordion c-leadership__accordion ] [ u-gap-top-plus-4 ]\">\n\n                <div class=\"c-block-anchor\" id=\"equipe-dirigeante\"><\/div>\n\n                <button class=\"[ c-accordion__title ] [ u-caps u-color-tan-2 u-text-base sm:u-text-plus-1 u-weight-bold ]\" aria-expanded=\"true\" data-starts-open data-disclosure-toggle=\"equipe-dirigeante\">\n\n                    Equipe dirigeante\n                    \n                    <span class=\"[ c-accordion__label ] [ u-text-minus-2 u-weight-light u-color-white ]\">\n                        <span class=\"c-icon c-accordion__icon\">\n                            <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 9.4 6.1\">\n  <path d=\"M4.7 6.1L0 1.4 1.4 0l3.3 3.3L8 0l1.4 1.4z\" data-name=\"Path 36\"\/>\n<\/svg>\n                        <\/span>\n                    <\/span>\n\n                <\/button>\n\n                <div class=\"[ c-accordion__panel ]\" aria-hidden=\"false\" data-disclosure-target=\"equipe-dirigeante\">\n\n                                            \n                        <div class=\"c-leadership__block-grid\">\n\n                            \n                        <\/div>\n                    \n                    \n                <\/div>\n\n            <\/div>\n\n                \n            <div class=\"[ c-accordion c-leadership__accordion ] [ u-gap-top-plus-4 ]\">\n\n                <div class=\"c-block-anchor\" id=\"conseil-dadministration\"><\/div>\n\n                <button class=\"[ c-accordion__title ] [ u-caps u-color-tan-2 u-text-base sm:u-text-plus-1 u-weight-bold ]\"  data-disclosure-toggle=\"conseil-dadministration\">\n\n                    Conseil d&rsquo;administration\n                    \n                    <span class=\"[ c-accordion__label ] [ u-text-minus-2 u-weight-light u-color-white ]\">\n                        <span class=\"c-icon c-accordion__icon\">\n                            <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 9.4 6.1\">\n  <path d=\"M4.7 6.1L0 1.4 1.4 0l3.3 3.3L8 0l1.4 1.4z\" data-name=\"Path 36\"\/>\n<\/svg>\n                        <\/span>\n                    <\/span>\n\n                <\/button>\n\n                <div class=\"[ c-accordion__panel ]\"  data-disclosure-target=\"conseil-dadministration\">\n\n                                            \n                        <div class=\"[ c-leadership__intro ] \">\n\n                            Le Conseil d\u2019administration de Nicox a une vaste exp\u00e9rience en ophtalmologie et en d\u00e9veloppement pharmaceutique\n\n                        <\/div>\n\n                        <div class=\"c-leadership__list-grid [ u-gap-top-base ]\">\n\n                            \n\n                            \n                        <\/div>\n                    \n                    \n                <\/div>\n\n            <\/div>\n\n        \n    <\/div>\n\n<\/section>\n\n\n<section class=\"[ c-partnerships c-wrapper ]\">\n\n    <div class=\"c-block-anchor\" id=\"ophthalmic-partnerships\"><\/div>\n\n    <div class=\"[ c-partnerships__container ] [ u-bg-white ] [  ]\">\n\n        \n            <h2 class=\"[ c-partnerships__title ] [ u-text-plus-1 sm:u-text-plus-2 u-weight-bold ]\">\n                Partenariats \n            <\/h2>\n    \n        \n        <div class=\"c-partnerships__grid\">\n\n            \n                                \n                <button class=\"c-partnerships__toggle\" >\n              \n                \n\n                                            <img decoding=\"async\" src=\"https:\/\/www.nicox.com\/wp-content\/uploads\/Harrow_logo_RGB-wTag-wR.png\" alt=\"\">\n                                        \n                    <span class=\"u-visually-hidden\">Harrow Health<\/span>\n                    \n                <\/button>\n\n                <div class=\"[ c-partnerships__detail ] [ u-bg-white ]\" data-disclosure-target=\"harrow-health\">\n\n                    <header class=\"[ c-detail-header ] [ u-links-plain ]\">\n\n                        <button class=\"c-detail__overlay\" data-disclosure-toggle=\"harrow-health\" data-close-details><\/button>\n\n                        <button class=\"[ c-icon-link c-detail__close ] [ u-text-minus-2 sm:u-text-base ]\" data-disclosure-toggle=\"harrow-health\" data-close-details data-variant=\"medium\">\n\n                            <span class=\"c-icon-link__text\">\n                                Fermer\n                            <\/span>\n\n                            <span class=\"c-icon c-icon-link__icon\" aria-hidden=\"true\">\n                                <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 73 73\">\n  <path d=\"M36.5 2c-4.7 0-9.2.9-13.4 2.7-4.1 1.7-7.8 4.2-11 7.4s-5.7 6.9-7.4 11C2.9 27.4 2 31.9 2 36.5s.9 9.2 2.7 13.4c1.7 4.1 4.2 7.8 7.4 11s6.9 5.7 11 7.4c4.3 1.8 8.8 2.7 13.4 2.7s9.2-.9 13.4-2.7c4.1-1.7 7.8-4.2 11-7.4s5.7-6.9 7.4-11c1.8-4.3 2.7-8.8 2.7-13.4s-.9-9.2-2.7-13.4c-1.7-4.1-4.2-7.8-7.4-11s-6.9-5.7-11-7.4C45.7 2.9 41.2 2 36.5 2m0-2C56.7 0 73 16.3 73 36.5S56.7 73 36.5 73 0 56.7 0 36.5 16.3 0 36.5 0z\"\/>\n  <path d=\"M15.06 55.774l39.951-39.951 1.415 1.414-39.952 39.951z\"\/>\n  <path d=\"M14.989 17.236l1.414-1.415 39.951 39.952-1.414 1.414z\"\/>\n<\/svg>\n                            <\/span>\n\n                        <\/button>\n\n                        \n                            <h2 class=\"[ c-partnerships__title ] [ u-text-plus-1 sm:u-text-plus-2 u-weight-bold ]\">\n                                Harrow Health\n                            <\/h2>\n                    \n                        \n                    <\/header>\n\n                    <hr class=\"u-gap-top-plus-3 u-color-grey-2\">\n\n                    \n                                            <img decoding=\"async\" class=\"u-gap-top-plus-3\" src=\"https:\/\/www.nicox.com\/wp-content\/uploads\/Harrow_logo_RGB-wTag-wR.png\" alt=\"\">\n                                    \n                <\/div>\n\n            \n                \n                <button class=\"c-partnerships__toggle\" data-disclosure-toggle=\"itrom-pharmaceutical-group\" data-open-details>\n               \n                \n\n                                            <img decoding=\"async\" src=\"https:\/\/www.nicox.com\/wp-content\/uploads\/Itrom-1.png\" alt=\"\">\n                                        \n                    <span class=\"u-visually-hidden\">ITROM Pharmaceutical Group  <\/span>\n                    \n                <\/button>\n\n                <div class=\"[ c-partnerships__detail ] [ u-bg-white ]\" data-disclosure-target=\"itrom-pharmaceutical-group\">\n\n                    <header class=\"[ c-detail-header ] [ u-links-plain ]\">\n\n                        <button class=\"c-detail__overlay\" data-disclosure-toggle=\"itrom-pharmaceutical-group\" data-close-details><\/button>\n\n                        <button class=\"[ c-icon-link c-detail__close ] [ u-text-minus-2 sm:u-text-base ]\" data-disclosure-toggle=\"itrom-pharmaceutical-group\" data-close-details data-variant=\"medium\">\n\n                            <span class=\"c-icon-link__text\">\n                                Fermer\n                            <\/span>\n\n                            <span class=\"c-icon c-icon-link__icon\" aria-hidden=\"true\">\n                                <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 73 73\">\n  <path d=\"M36.5 2c-4.7 0-9.2.9-13.4 2.7-4.1 1.7-7.8 4.2-11 7.4s-5.7 6.9-7.4 11C2.9 27.4 2 31.9 2 36.5s.9 9.2 2.7 13.4c1.7 4.1 4.2 7.8 7.4 11s6.9 5.7 11 7.4c4.3 1.8 8.8 2.7 13.4 2.7s9.2-.9 13.4-2.7c4.1-1.7 7.8-4.2 11-7.4s5.7-6.9 7.4-11c1.8-4.3 2.7-8.8 2.7-13.4s-.9-9.2-2.7-13.4c-1.7-4.1-4.2-7.8-7.4-11s-6.9-5.7-11-7.4C45.7 2.9 41.2 2 36.5 2m0-2C56.7 0 73 16.3 73 36.5S56.7 73 36.5 73 0 56.7 0 36.5 16.3 0 36.5 0z\"\/>\n  <path d=\"M15.06 55.774l39.951-39.951 1.415 1.414-39.952 39.951z\"\/>\n  <path d=\"M14.989 17.236l1.414-1.415 39.951 39.952-1.414 1.414z\"\/>\n<\/svg>\n                            <\/span>\n\n                        <\/button>\n\n                        \n                            <h2 class=\"[ c-partnerships__title ] [ u-text-plus-1 sm:u-text-plus-2 u-weight-bold ]\">\n                                ITROM Pharmaceutical Group  \n                            <\/h2>\n                    \n                        \n                    <\/header>\n\n                    <hr class=\"u-gap-top-plus-3 u-color-grey-2\">\n\n                    \n                        <div class=\"c-partnerships__info\">\n\n                            <p>Nicox a conclu un accord de concession de licence exclusif avec ITROM Pharmaceutical Group pour le d\u00e9veloppement et la commercialisation de <a href=\"https:\/\/www.nicox.com\/fr\/portefeuille-de-therapeutiques-ophtalmiques\/#product-zerviate\">ZERVIATE<sup>\u00ae <\/sup><\/a>dans les march\u00e9s des Etats Arabes du Golfe.<\/p>\n<p>ITROM est une organisation pharmaceutique bas\u00e9e \u00e0 Duba\u00ef qui a plus de 20 ans d\u2019exp\u00e9rience dans le march\u00e9 ophtalmologique r\u00e9gional.<\/p>\n<p>Le groupe a pour objectif de proposer des produits pharmaceutiques innovants dans la r\u00e9gion du Moyen Orient et de l\u2019Afrique du Nord ; l\u2019essentiel de ses activit\u00e9s de d\u00e9veloppement se concentre sur l\u2019ophtalmologie et la sant\u00e9 de la femme<\/p>\n\n\n                        <\/div>\n\n                    \n                                            <img decoding=\"async\" class=\"u-gap-top-plus-3\" src=\"https:\/\/www.nicox.com\/wp-content\/uploads\/Itrom-1.png\" alt=\"\">\n                                    \n                <\/div>\n\n            \n                \n                <button class=\"c-partnerships__toggle\" data-disclosure-toggle=\"ocumension-therapeutics\" data-open-details>\n               \n                \n\n                                            <img decoding=\"async\" src=\"https:\/\/www.nicox.com\/wp-content\/uploads\/ocumension-logo.jpg\" alt=\"\">\n                                        \n                    <span class=\"u-visually-hidden\">Ocumension Therapeutics<\/span>\n                    \n                <\/button>\n\n                <div class=\"[ c-partnerships__detail ] [ u-bg-white ]\" data-disclosure-target=\"ocumension-therapeutics\">\n\n                    <header class=\"[ c-detail-header ] [ u-links-plain ]\">\n\n                        <button class=\"c-detail__overlay\" data-disclosure-toggle=\"ocumension-therapeutics\" data-close-details><\/button>\n\n                        <button class=\"[ c-icon-link c-detail__close ] [ u-text-minus-2 sm:u-text-base ]\" data-disclosure-toggle=\"ocumension-therapeutics\" data-close-details data-variant=\"medium\">\n\n                            <span class=\"c-icon-link__text\">\n                                Fermer\n                            <\/span>\n\n                            <span class=\"c-icon c-icon-link__icon\" aria-hidden=\"true\">\n                                <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 73 73\">\n  <path d=\"M36.5 2c-4.7 0-9.2.9-13.4 2.7-4.1 1.7-7.8 4.2-11 7.4s-5.7 6.9-7.4 11C2.9 27.4 2 31.9 2 36.5s.9 9.2 2.7 13.4c1.7 4.1 4.2 7.8 7.4 11s6.9 5.7 11 7.4c4.3 1.8 8.8 2.7 13.4 2.7s9.2-.9 13.4-2.7c4.1-1.7 7.8-4.2 11-7.4s5.7-6.9 7.4-11c1.8-4.3 2.7-8.8 2.7-13.4s-.9-9.2-2.7-13.4c-1.7-4.1-4.2-7.8-7.4-11s-6.9-5.7-11-7.4C45.7 2.9 41.2 2 36.5 2m0-2C56.7 0 73 16.3 73 36.5S56.7 73 36.5 73 0 56.7 0 36.5 16.3 0 36.5 0z\"\/>\n  <path d=\"M15.06 55.774l39.951-39.951 1.415 1.414-39.952 39.951z\"\/>\n  <path d=\"M14.989 17.236l1.414-1.415 39.951 39.952-1.414 1.414z\"\/>\n<\/svg>\n                            <\/span>\n\n                        <\/button>\n\n                        \n                            <h2 class=\"[ c-partnerships__title ] [ u-text-plus-1 sm:u-text-plus-2 u-weight-bold ]\">\n                                Ocumension Therapeutics\n                            <\/h2>\n                    \n                        \n                    <\/header>\n\n                    <hr class=\"u-gap-top-plus-3 u-color-grey-2\">\n\n                    \n                        <div class=\"c-partnerships__info\">\n\n                            <p>Nicox a conclu des accords de concession de licence exclusifs avec Ocumension Therapeutics pour le d\u00e9veloppement et la commercialisation de\u00a0 <a href=\"https:\/\/www.nicox.com\/fr\/portefeuille-de-therapeutiques-ophtalmiques\/#product-zerviate\">ZERVIATE<sup>\u00ae<\/sup><\/a> et <a href=\"https:\/\/www.nicox.com\/fr\/portefeuille-de-therapeutiques-ophtalmiques\/#product-ncx-470\">NCX 470<\/a> pour les march\u00e9s chinois et d\u2019Asie du Sud-Est ainsi que pour <a href=\"https:\/\/www.nicox.com\/fr\/portefeuille-de-therapeutiques-ophtalmiques\/#product-ncx-4251\">NCX 4251<\/a> pour le march\u00e9 chinois.<\/p>\n<p>Ocumension Therapeutics est une soci\u00e9t\u00e9 d\u2019ophtalmologie bas\u00e9e en Chine, cot\u00e9e \u00e0 la bourse de Hong Kong, qui se consacre \u00e0 l\u2019identification, au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies ophtalmiques les premi\u00e8res ou meilleures de leurs classes.<\/p>\n\n\n                        <\/div>\n\n                    \n                                            <img decoding=\"async\" class=\"u-gap-top-plus-3\" src=\"https:\/\/www.nicox.com\/wp-content\/uploads\/ocumension-logo.jpg\" alt=\"\">\n                                    \n                <\/div>\n\n            \n                \n                <button class=\"c-partnerships__toggle\" data-disclosure-toggle=\"bausch-lomb\" data-open-details>\n               \n                \n\n                                            <img decoding=\"async\" src=\"https:\/\/www.nicox.com\/wp-content\/uploads\/Bausch-Lomb-logo-e1707390842791.png\" alt=\"\">\n                                        \n                    <span class=\"u-visually-hidden\">Bausch + Lomb<\/span>\n                    \n                <\/button>\n\n                <div class=\"[ c-partnerships__detail ] [ u-bg-white ]\" data-disclosure-target=\"bausch-lomb\">\n\n                    <header class=\"[ c-detail-header ] [ u-links-plain ]\">\n\n                        <button class=\"c-detail__overlay\" data-disclosure-toggle=\"bausch-lomb\" data-close-details><\/button>\n\n                        <button class=\"[ c-icon-link c-detail__close ] [ u-text-minus-2 sm:u-text-base ]\" data-disclosure-toggle=\"bausch-lomb\" data-close-details data-variant=\"medium\">\n\n                            <span class=\"c-icon-link__text\">\n                                Fermer\n                            <\/span>\n\n                            <span class=\"c-icon c-icon-link__icon\" aria-hidden=\"true\">\n                                <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 73 73\">\n  <path d=\"M36.5 2c-4.7 0-9.2.9-13.4 2.7-4.1 1.7-7.8 4.2-11 7.4s-5.7 6.9-7.4 11C2.9 27.4 2 31.9 2 36.5s.9 9.2 2.7 13.4c1.7 4.1 4.2 7.8 7.4 11s6.9 5.7 11 7.4c4.3 1.8 8.8 2.7 13.4 2.7s9.2-.9 13.4-2.7c4.1-1.7 7.8-4.2 11-7.4s5.7-6.9 7.4-11c1.8-4.3 2.7-8.8 2.7-13.4s-.9-9.2-2.7-13.4c-1.7-4.1-4.2-7.8-7.4-11s-6.9-5.7-11-7.4C45.7 2.9 41.2 2 36.5 2m0-2C56.7 0 73 16.3 73 36.5S56.7 73 36.5 73 0 56.7 0 36.5 16.3 0 36.5 0z\"\/>\n  <path d=\"M15.06 55.774l39.951-39.951 1.415 1.414-39.952 39.951z\"\/>\n  <path d=\"M14.989 17.236l1.414-1.415 39.951 39.952-1.414 1.414z\"\/>\n<\/svg>\n                            <\/span>\n\n                        <\/button>\n\n                        \n                            <h2 class=\"[ c-partnerships__title ] [ u-text-plus-1 sm:u-text-plus-2 u-weight-bold ]\">\n                                Bausch + Lomb\n                            <\/h2>\n                    \n                        \n                    <\/header>\n\n                    <hr class=\"u-gap-top-plus-3 u-color-grey-2\">\n\n                    \n                        <div class=\"c-partnerships__info\">\n\n                            <p>Nicox a sign\u00e9 un accord de licence exclusif mondial avec Bausch + Lomb lui allouant les droits exclusifs mondiaux de d\u00e9veloppement et de commercialisation du latanoprost\u00e8ne bunod, commercialis\u00e9 sous le nom de <a href=\"https:\/\/www.nicox.com\/fr\/portefeuille-de-therapeutiques-ophtalmiques\/#product-vyzulta\">VYZULTA<sup><span style=\"font-family: Liberation Serif, serif;\">\u00ae<\/span><\/sup><\/a>.<\/p>\n<p>Nicox a vendu les redevances de VYZULTA \u00e0 Soleus Capital en octobre 2024.<\/p>\n<p>Bausch + Lomb, un leader mondial de la sant\u00e9 oculaire, se consacre \u00e0 aider les gens \u00e0 mieux voir pour mieux vivre.<\/p>\n<p>Ses activit\u00e9s principales incluent des produits en vente libre, des suppl\u00e9ments di\u00e9t\u00e9tiques, des produits de soins de la vue, des produits pharmaceutiques ophtalmiques, des lentilles de contact, des produits de soin des lentilles de contact, des appareils et instruments de chirurgie ophtalmique.<\/p>\n\n\n                        <\/div>\n\n                    \n                                            <img decoding=\"async\" class=\"u-gap-top-plus-3\" src=\"https:\/\/www.nicox.com\/wp-content\/uploads\/Bausch-Lomb-logo-e1707390842791.png\" alt=\"\">\n                                    \n                <\/div>\n\n            \n                \n                <button class=\"c-partnerships__toggle\" data-disclosure-toggle=\"samil-pharmaceutical-co-ltd\" data-open-details>\n               \n                \n\n                                            <img decoding=\"async\" src=\"https:\/\/www.nicox.com\/wp-content\/uploads\/samil-logo.png\" alt=\"\">\n                                        \n                    <span class=\"u-visually-hidden\">Samil Pharmaceutical Co., Ltd<\/span>\n                    \n                <\/button>\n\n                <div class=\"[ c-partnerships__detail ] [ u-bg-white ]\" data-disclosure-target=\"samil-pharmaceutical-co-ltd\">\n\n                    <header class=\"[ c-detail-header ] [ u-links-plain ]\">\n\n                        <button class=\"c-detail__overlay\" data-disclosure-toggle=\"samil-pharmaceutical-co-ltd\" data-close-details><\/button>\n\n                        <button class=\"[ c-icon-link c-detail__close ] [ u-text-minus-2 sm:u-text-base ]\" data-disclosure-toggle=\"samil-pharmaceutical-co-ltd\" data-close-details data-variant=\"medium\">\n\n                            <span class=\"c-icon-link__text\">\n                                Fermer\n                            <\/span>\n\n                            <span class=\"c-icon c-icon-link__icon\" aria-hidden=\"true\">\n                                <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 73 73\">\n  <path d=\"M36.5 2c-4.7 0-9.2.9-13.4 2.7-4.1 1.7-7.8 4.2-11 7.4s-5.7 6.9-7.4 11C2.9 27.4 2 31.9 2 36.5s.9 9.2 2.7 13.4c1.7 4.1 4.2 7.8 7.4 11s6.9 5.7 11 7.4c4.3 1.8 8.8 2.7 13.4 2.7s9.2-.9 13.4-2.7c4.1-1.7 7.8-4.2 11-7.4s5.7-6.9 7.4-11c1.8-4.3 2.7-8.8 2.7-13.4s-.9-9.2-2.7-13.4c-1.7-4.1-4.2-7.8-7.4-11s-6.9-5.7-11-7.4C45.7 2.9 41.2 2 36.5 2m0-2C56.7 0 73 16.3 73 36.5S56.7 73 36.5 73 0 56.7 0 36.5 16.3 0 36.5 0z\"\/>\n  <path d=\"M15.06 55.774l39.951-39.951 1.415 1.414-39.952 39.951z\"\/>\n  <path d=\"M14.989 17.236l1.414-1.415 39.951 39.952-1.414 1.414z\"\/>\n<\/svg>\n                            <\/span>\n\n                        <\/button>\n\n                        \n                            <h2 class=\"[ c-partnerships__title ] [ u-text-plus-1 sm:u-text-plus-2 u-weight-bold ]\">\n                                Samil Pharmaceutical Co., Ltd\n                            <\/h2>\n                    \n                        \n                    <\/header>\n\n                    <hr class=\"u-gap-top-plus-3 u-color-grey-2\">\n\n                    \n                        <div class=\"c-partnerships__info\">\n\n                            <p>Nicox a conclu un accord de concession de licence exclusif avec Samil Pharmaceutical pour le d\u00e9veloppement et la commercialisation en Cor\u00e9e du Sud de <a href=\"https:\/\/www.nicox.com\/fr\/portefeuille-de-therapeutiques-ophtalmiques\/#product-zerviate\">ZERVIATE\u2122<\/a>.<\/p>\n<p>Samil Pharmaceutical, fort d\u2019une exp\u00e9rience de 71 ann\u00e9es dans l\u2019industrie pharmaceutique, est consid\u00e9r\u00e9e comme l\u2019une des soci\u00e9t\u00e9s cor\u00e9ennes de premier plan sp\u00e9cialis\u00e9e dans les th\u00e9rapies ophtalmiques, dont la recherche et le d\u00e9veloppement de m\u00e9dicaments dans le domaine de l\u2019ophtalmologie.<\/p>\n\n\n                        <\/div>\n\n                    \n                                            <img decoding=\"async\" class=\"u-gap-top-plus-3\" src=\"https:\/\/www.nicox.com\/wp-content\/uploads\/samil-logo.png\" alt=\"\">\n                                    \n                <\/div>\n\n            \n                \n                <button class=\"c-partnerships__toggle\" data-disclosure-toggle=\"kowa\" data-open-details>\n               \n                \n\n                                            <img decoding=\"async\" src=\"https:\/\/www.nicox.com\/wp-content\/uploads\/kowa_mark_red_RGB.png\" alt=\"\">\n                                        \n                    <span class=\"u-visually-hidden\">Kowa<\/span>\n                    \n                <\/button>\n\n                <div class=\"[ c-partnerships__detail ] [ u-bg-white ]\" data-disclosure-target=\"kowa\">\n\n                    <header class=\"[ c-detail-header ] [ u-links-plain ]\">\n\n                        <button class=\"c-detail__overlay\" data-disclosure-toggle=\"kowa\" data-close-details><\/button>\n\n                        <button class=\"[ c-icon-link c-detail__close ] [ u-text-minus-2 sm:u-text-base ]\" data-disclosure-toggle=\"kowa\" data-close-details data-variant=\"medium\">\n\n                            <span class=\"c-icon-link__text\">\n                                Fermer\n                            <\/span>\n\n                            <span class=\"c-icon c-icon-link__icon\" aria-hidden=\"true\">\n                                <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 73 73\">\n  <path d=\"M36.5 2c-4.7 0-9.2.9-13.4 2.7-4.1 1.7-7.8 4.2-11 7.4s-5.7 6.9-7.4 11C2.9 27.4 2 31.9 2 36.5s.9 9.2 2.7 13.4c1.7 4.1 4.2 7.8 7.4 11s6.9 5.7 11 7.4c4.3 1.8 8.8 2.7 13.4 2.7s9.2-.9 13.4-2.7c4.1-1.7 7.8-4.2 11-7.4s5.7-6.9 7.4-11c1.8-4.3 2.7-8.8 2.7-13.4s-.9-9.2-2.7-13.4c-1.7-4.1-4.2-7.8-7.4-11s-6.9-5.7-11-7.4C45.7 2.9 41.2 2 36.5 2m0-2C56.7 0 73 16.3 73 36.5S56.7 73 36.5 73 0 56.7 0 36.5 16.3 0 36.5 0z\"\/>\n  <path d=\"M15.06 55.774l39.951-39.951 1.415 1.414-39.952 39.951z\"\/>\n  <path d=\"M14.989 17.236l1.414-1.415 39.951 39.952-1.414 1.414z\"\/>\n<\/svg>\n                            <\/span>\n\n                        <\/button>\n\n                        \n                            <h2 class=\"[ c-partnerships__title ] [ u-text-plus-1 sm:u-text-plus-2 u-weight-bold ]\">\n                                Kowa\n                            <\/h2>\n                    \n                        \n                    <\/header>\n\n                    <hr class=\"u-gap-top-plus-3 u-color-grey-2\">\n\n                    \n                        <div class=\"c-partnerships__info\">\n\n                            <p>Nicox a conclu un contrat de concession de licence exclusif avec Kowa Company, Ltd pour le d\u00e9veloppement et la commercialisation de <a href=\"https:\/\/www.nicox.com\/fr\/portefeuille-de-therapeutiques-ophtalmiques\/#product-ncx-470\">NCX 470<\/a> au Japon et dans l&rsquo;ensemble des territoires du monde en dehors de la Chine, de la Cor\u00e9e et de l&rsquo;Asie du Sud-Est.<\/p>\n<p>Kowa est une soci\u00e9t\u00e9 multinationale priv\u00e9e dont le si\u00e8ge est \u00e0 Nagoya, au Japon. Fond\u00e9e en 1894, Kowa est activement engag\u00e9e dans divers secteurs d\u2019activit\u00e9, notamment le commerce de textiles, de machines et de mat\u00e9riaux de construction, en plus de la fabrication et de la vente de m\u00e9dicaments, d&rsquo;\u00e9quipements m\u00e9dicaux, d\u2019instruments optiques, ainsi que de produits d&rsquo;\u00e9conomie d&rsquo;\u00e9nergie et de cr\u00e9ation d&rsquo;\u00e9nergie.<\/p>\n<p>L\u2019activit\u00e9 pharmaceutique de Kowa se concentre sur la recherche et le d\u00e9veloppement de trois activit\u00e9s principales dans les maladies li\u00e9es au mode de vie (dyslipid\u00e9mie, diab\u00e8te de type 2 et ath\u00e9roscl\u00e9rose), l\u2019ophtalmologie et les agents anti-inflammatoires.<\/p>\n<p>Pour plus d&rsquo;informations <a href=\"https:\/\/www.kowa.co.jp\/eng\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.kowa.co.jp\/eng\/<\/a><\/p>\n\n\n                        <\/div>\n\n                    \n                                            <img decoding=\"async\" class=\"u-gap-top-plus-3\" src=\"https:\/\/www.nicox.com\/wp-content\/uploads\/kowa_mark_red_RGB.png\" alt=\"\">\n                                    \n                <\/div>\n\n            \n        <\/div>\n\n        \n            <p class=\"c-partnerships__disclaimer ] [ u-text-minus-2 ]\">\n                <b>Pour plus d&rsquo;informations cliquer sur le logo d&rsquo;un partenaire<\/b><br \/>\r\nToutes les informations sur les partenariats conclus par la Soci\u00e9t\u00e9 sont disponibles dans le rapport annuel et les communiqu\u00e9s de presse ult\u00e9rieurs.<br \/>\r\n\n            <\/p>\n\n            \n    <\/div>\n\n<\/section>\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-9211","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>A propos de Nicox - Nicox<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.nicox.com\/fr\/about-us\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A propos de Nicox - Nicox\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.nicox.com\/fr\/about-us\/\" \/>\n<meta property=\"og:site_name\" content=\"Nicox\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-04T08:24:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.nicox.com\/wp-content\/uploads\/Nicox_opticien.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/about-us\\\/\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/about-us\\\/\",\"name\":\"A propos de Nicox - Nicox\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/about-us\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/about-us\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.nicox.com\\\/wp-content\\\/uploads\\\/Nicox_opticien.jpg\",\"datePublished\":\"2021-07-07T16:50:34+00:00\",\"dateModified\":\"2025-09-04T08:24:54+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.nicox.com\\\/fr\\\/about-us\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/about-us\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/wp-content\\\/uploads\\\/Nicox_opticien.jpg\",\"contentUrl\":\"https:\\\/\\\/www.nicox.com\\\/wp-content\\\/uploads\\\/Nicox_opticien.jpg\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"name\":\"Nicox\",\"description\":\"Visible Science\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\",\"name\":\"Nicox\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Nicox\"},\"image\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A propos de Nicox - Nicox","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.nicox.com\/fr\/about-us\/","og_locale":"fr_FR","og_type":"article","og_title":"A propos de Nicox - Nicox","og_url":"https:\/\/www.nicox.com\/fr\/about-us\/","og_site_name":"Nicox","article_modified_time":"2025-09-04T08:24:54+00:00","og_image":[{"url":"https:\/\/www.nicox.com\/wp-content\/uploads\/Nicox_opticien.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.nicox.com\/fr\/about-us\/","url":"https:\/\/www.nicox.com\/fr\/about-us\/","name":"A propos de Nicox - Nicox","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.nicox.com\/fr\/about-us\/#primaryimage"},"image":{"@id":"https:\/\/www.nicox.com\/fr\/about-us\/#primaryimage"},"thumbnailUrl":"https:\/\/www.nicox.com\/wp-content\/uploads\/Nicox_opticien.jpg","datePublished":"2021-07-07T16:50:34+00:00","dateModified":"2025-09-04T08:24:54+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.nicox.com\/fr\/about-us\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.nicox.com\/fr\/about-us\/#primaryimage","url":"https:\/\/www.nicox.com\/wp-content\/uploads\/Nicox_opticien.jpg","contentUrl":"https:\/\/www.nicox.com\/wp-content\/uploads\/Nicox_opticien.jpg"},{"@type":"WebSite","@id":"https:\/\/www.nicox.com\/fr\/#website","url":"https:\/\/www.nicox.com\/fr\/","name":"Nicox","description":"Visible Science","publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.nicox.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.nicox.com\/fr\/#organization","name":"Nicox","url":"https:\/\/www.nicox.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Nicox"},"image":{"@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/pages\/9211","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/comments?post=9211"}],"version-history":[{"count":10,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/pages\/9211\/revisions"}],"predecessor-version":[{"id":18177,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/pages\/9211\/revisions\/18177"}],"wp:attachment":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/media?parent=9211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}